Nordea Investment Management’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.66M | Buy |
17,055
+469
| +3% | +$89.7K | ﹤0.01% | 672 |
|
|
2026
Q1 | $2.96M | Buy |
16,586
+2,564
| +18% | +$472K | ﹤0.01% | 689 |
|
|
2025
Q4 | $2.46M | Sell |
14,022
-118,561
| -89% | -$19.4M | ﹤0.01% | 720 |
|
|
2025
Q3 | $18.2M | Buy |
132,583
+6,648
| +5% | +$899K | 0.02% | 348 |
|
|
2025
Q2 | $15.8M | Buy |
125,935
+6,811
| +6% | +$849K | 0.01% | 353 |
|
|
2025
Q1 | $16.3M | Buy |
119,124
+1,161
| +1% | +$166K | 0.02% | 340 |
|
|
2024
Q4 | $17.9M | Buy |
117,963
+38,283
| +48% | +$6.46M | 0.02% | 335 |
|
|
2024
Q3 | $15.4M | Sell |
79,680
-29,794
| -27% | -$6.23M | 0.02% | 351 |
|
|
2024
Q2 | $25.7M | Buy |
109,474
+4,098
| +4% | +$891K | 0.03% | 305 |
|
|
2024
Q1 | $22.7M | Sell |
105,376
-31,354
| -23% | -$7.34M | 0.03% | 327 |
|
|
2023
Q4 | $35.4M | Sell |
136,730
-81,258
| -37% | -$20M | 0.04% | 278 |
|
|
2023
Q3 | $56.4M | Buy |
217,988
+78,335
| +56% | +$21M | 0.08% | 223 |
|
|
2023
Q2 | $39.7M | Sell |
139,653
-290,317
| -68% | -$86.4M | 0.05% | 260 |
|
|
2023
Q1 | $119M | Buy |
429,970
+6,005
| +1% | +$1.66M | 0.17% | 147 |
|
|
2022
Q4 | $116M | Buy |
423,965
+8,925
| +2% | +$2.52M | 0.18% | 146 |
|
|
2022
Q3 | $107M | Sell |
415,040
-6,408
| -2% | -$1.36M | 0.17% | 146 |
|
|
2022
Q2 | $85M | Sell |
421,448
-26,497
| -6% | -$5.42M | 0.13% | 176 |
|
|
2022
Q1 | $94.8M | Sell |
447,945
-3,166
| -0.7% | -$688K | 0.12% | 181 |
|
|
2021
Q4 | $109M | Sell |
451,111
-5,875
| -1% | -$1.51M | 0.13% | 172 |
|
|
2021
Q3 | $131M | Buy |
456,986
+11,987
| +3% | +$3.93M | 0.17% | 151 |
|
|
2021
Q2 | $154M | Sell |
444,999
-68,522
| -13% | -$20.8M | 0.21% | 134 |
|
|
2021
Q1 | $142M | Sell |
513,521
-3,741
| -0.7% | -$1.01M | 0.21% | 129 |
|
|
2020
Q4 | $127M | Sell |
517,262
-3,108
| -0.6% | -$802K | 0.2% | 131 |
|
|
2020
Q3 | $147M | Sell |
520,370
-566,816
| -52% | -$158M | 0.28% | 84 |
|
|
2020
Q2 | $284M | Buy |
1,087,186
+566,347
| +109% | +$170M | 0.29% | 75 |
|
|
2020
Q1 | $162M | Sell |
520,839
-1,202
| -0.2% | -$365K | 0.39% | 66 |
|
|
2019
Q4 | $155M | Buy |
522,041
+8,660
| +2% | +$2.4M | 0.31% | 79 |
|
|
2019
Q3 | $119M | Buy |
513,381
+9,080
| +2% | +$2.11M | 0.26% | 87 |
|
|
2019
Q2 | $118M | Sell |
504,301
-18,935
| -4% | -$4.37M | 0.26% | 87 |
|
|
2019
Q1 | $124M | Buy |
523,236
+97,622
| +23% | +$30.7M | 0.26% | 87 |
|
|
2018
Q4 | $128M | Buy |
425,614
+2,576
| +0.6% | +$822K | 0.3% | 74 |
|
|
2018
Q3 | $149M | Sell |
423,038
-2,510
| -0.6% | -$864K | 0.31% | 75 |
|
|
2018
Q2 | $124M | Sell |
425,548
-525
| -0.1% | -$148K | 0.3% | 77 |
|
|
2018
Q1 | $117M | Buy |
426,073
+66,647
| +19% | +$20.7M | 0.28% | 78 |
|
|
2017
Q4 | $115M | Buy |
359,426
+5,710
| +2% | +$1.83M | 0.27% | 78 |
|
|
2017
Q3 | $111M | Buy |
353,716
+11,933
| +3% | +$3.53M | 0.27% | 84 |
|
|
2017
Q2 | $92.7M | Buy |
341,783
+3,525
| +1% | +$932K | 0.23% | 99 |
|
|
2017
Q1 | $92.5M | Sell |
338,258
-74,597
| -18% | -$21.1M | 0.24% | 98 |
|
|
2016
Q4 | $117M | Buy |
412,855
+2,641
| +0.6% | +$783K | 0.31% | 74 |
|
|
2016
Q3 | $128M | Buy |
410,214
+17,156
| +4% | +$5.08M | 0.33% | 73 |
|
|
2016
Q2 | $95M | Sell |
393,058
-34,569
| -8% | -$9.11M | 0.27% | 85 |
|
|
2016
Q1 | $111M | Buy |
427,627
+267,607
| +167% | +$70.7M | 0.34% | 81 |
|
|
2015
Q4 | $49M | Buy |
160,020
+133,149
| +496% | +$38.3M | 0.17% | 131 |
|
|
2015
Q3 | $7.84M | Buy |
26,871
+338
| +1% | +$112K | 0.03% | 228 |
|
|
2015
Q2 | $10.7M | Buy |
26,533
+18,097
| +215% | +$7.26M | 0.04% | 214 |
|
|
2015
Q1 | $3.56M | Sell |
8,436
-10,332
| -55% | -$4.07M | 0.01% | 273 |
|
|
2014
Q4 | $6.37M | Sell |
18,768
-905
| -5% | -$293K | 0.02% | 243 |
|
|
2014
Q3 | $6.51M | Sell |
19,673
-4,112
| -17% | -$1.36M | 0.03% | 241 |
|
|
2014
Q2 | $7.5M | Buy |
23,785
+894
| +4% | +$269K | 0.03% | 252 |
|
|
2014
Q1 | $7M | Buy |
22,891
+2,806
| +14% | +$891K | 0.03% | 253 |
|
|
2013
Q4 | $5.62M | Buy |
20,085
+2,143
| +12% | +$554K | 0.03% | 270 |
|
|
2013
Q3 | $4.32M | Hold |
17,942
| – | – | 0.02% | 304 |
|
|
2013
Q2 | $3.86M | Buy |
+17,942
| New | +$3.83M | 0.02% | 309 |
|
Other funds holding BIIB
AIM
Nordea Investment Management's BIIB Position: Q2 2026 in Review
Nordea Investment Management increased its Biogen (BIIB) stake by 2.8% in Q2 2026, buying an estimated $89.7K and bringing the position to 17,055 shares worth $3.66M. The position accounts for ﹤0.01% of the portfolio, ranked #672.
Nordea Investment Management first reported a position in BIIB in Q2 2013 and has held it in 53 quarters since. The position peaked at $284M in Q2 2020. 525 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.
- Nordea Investment Management held 17,055 shares of Biogen worth $3.66M as of Q2 2026.
- Nordea Investment Management bought 469 Biogen shares in Q2 2026, an estimated $89.7K.
- Biogen made up ﹤0.01% of Nordea Investment Management's portfolio in Q2 2026, its #672 holding.
- Nordea Investment Management first reported a position in Biogen in Q2 2013 and has held it in 53 quarters since.
- Nordea Investment Management's Biogen position peaked at $284M in Q2 2020.
- 525 funds tracked by Wall St. Rank held Biogen as of Q2 2026.
Based on Nordea Investment Management's 13F filing for Q2 2026, filed 5 Aug 2026.